TI
ACAD icon

Turner Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Turner Investments’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,000
Closed -$188K – 22
2017
Q3 		$188K Buy
+5,000
New +$163K 0.85% 54
2017
Q2 		– Sell
-31,000
Closed -$1.07M – 237
2017
Q1 		$1.07M Buy
31,000
+9,000
+41% +$318K 0.69% 57
2016
Q4 		$634K Buy
+22,000
New +$582K 0.26% 132
2014
Q1 		– Sell
-165,412
Closed -$4.13M – 637
2013
Q4 		$4.13M Sell
165,412
-1,011,076
-86% -$23.9M 0.07% 277
2013
Q3 		$32.3M Sell
1,176,488
-696,406
-37% -$14.6M 0.53% 48
2013
Q2 		$34M Buy
+1,872,894
New +$25.8M 0.46% 55

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Turner Investments's ACAD Position: Q4 2017 in Review

Turner Investments sold out of Acadia Pharmaceuticals (ACAD) in Q4 2017, closing a stake of 5,000 shares — an estimated $188K sold.

Turner Investments first reported a position in ACAD in Q2 2013 and held it in 6 quarters. The position peaked at $34M in Q2 2013. 210 funds tracked by Wall St. Rank hold ACAD as of Q4 2017.

  • Turner Investments reported no remaining Acadia Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Turner Investments sold 5,000 Acadia Pharmaceuticals shares in Q4 2017, an estimated $188K.
  • Turner Investments first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Turner Investments's Acadia Pharmaceuticals position peaked at $34M in Q2 2013.
  • 210 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2017.

Based on Turner Investments's 13F filing for Q4 2017, filed 2 Feb 2018.